Table 1.
Baseline characteristics of patients who started hemodialysis at CHM in the period 2017 to 2021, according to dialysis modality
| Dialysis frequency |
Nonstandard |
|||||
|---|---|---|---|---|---|---|
| Standard | Nonstandard | P value | Incremental | Decremental | P value for comparison of standard, incremental, and decremental groups | |
| N | 53 | 105 | 91 | 14 | ||
| Age (yr), median (min-max) | 71 (32–90) | 69 (26–94) | 0.908 | 70 (26–94) | 69 (38–91) | 0.815 |
| Sex, n females (%) | 22 (41.5) | 42 (40.0) | 0.855 | 35 (38.5) | 7 (50.0) | 0.703 |
| CCI, median (min-max) | 8 (2–13) | 8 (2–18) | 0.619 | 8 (2–18) | 7 (3–17) | 0.208 |
| SGA, n (%) | 0.086 | 0.146 | ||||
| A | 34 (65.4) | 82 (78.9) | 69 (76.7) | 13 (92.9) | ||
| B | 17 (32.7) | 18 (17.3) | 17 (18.9) | 1 (7.1) | ||
| C | 1 (1.9) | 4 (3.8) | 4 (4.4) | 0 | ||
| BMI (kg/m-2), median (min–max) | 25.6 (16.4–79.9) | 27.0 (16.3–47.4) | 0.619 | 26.5 (16.3–47.4) | 27.9 (18.6–37.0) | 0.841 |
| BMI ≥30, n (%) | 13 (31.4) | 34 (32.4) | 0.899 | 31 (34.1) | 3 (21.4) | 0.636 |
| Start in hospitalization, n (%) | 46 (86.8) | 70 (67.3) | 0.009 | 56 (62.2) | 14 (100) | <0.001 |
| Start in emergency, n (%) | 39 (73.6) | 40 (38.1) | <0.001 | 31 (34.1) | 9 (64.3) | <0.001 |
| Origin, n (%) | <0.001 | <0.001 | ||||
| Conventional predialysis care | 25 (47.2) | 31 (29.5) | 22 (24.2) | 9 (64.3) | ||
| Intensive predialysis care | 3 (5.7) | 48 (45.7) | 47 (51.7) | 1 (7.1) | ||
| Peritoneal dialysis | 1 (1.9) | 8 (7.6) | 8 (8.8) | 0 | ||
| Transplantation | 4 (7.6) | 5 (4.8) | 5 (5.5) | 0 | ||
| Other | 20 (37.7) | 13 (12.4) | 9 (9.9) | 4 (28.6) | ||
| Time of previous follow-up, (mo) n (%) | 0.026 | 0.051 | ||||
| 0 | 17 (32.1) | 15 (14.3) | 11 (12.1) | 4 (28.6) | ||
| 3 | 0 | 5 (4.8) | 4 (4.4) | 1 (7.1) | ||
| 6 | 5 (9.4) | 8 (7.6) | 8 (8.8) | 0 | ||
| ≥12 | 31 (58.5) | 77 (73.3) | 68 (74.7) | 9 (64.3) | ||
| CKD disease, n (%) | 0.763 | 0.798 | ||||
| Diabetes, nephroangiosclerosis | 26 (49.1) | 58 (55.2) | 52 (57.1) | 6 (42.9) | ||
| Glomerulonephritis | 8 (15.1) | 14 (13.3) | 12 (13.2) | 2 (14.3) | ||
| Other | 19 (35.9) | 33 (31.4) | 27 (29.7) | 6 (42.9) | ||
| eGFR (ml/min per 1.72 m2) at dialysis start, median (min–max) (all cases) | 5 (2–29) | 7 (2–40) | 0.003 | 7 (2–40) | 7 (2–10) | 0.002 |
| eGFR (ml/min per 1.72 m2) at dialysis start, median (min-max) (only for planned start of dialysis, excluding cardiorenal syndromes) | 5 (4–8) | 7 (3–15) | 0.007 | 7 (3–15) | 7 (6–10) | 0.019a |
BMI, body mass index; CCI, Charlson comorbidity index; CHM, Centre Hospitalier le Mans; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate according to the CKD-Epidemiology Collaboration formula; max, maximum; min, minimum; SGA, subjective global assessment.
Bold value indicates significant differences.
a
P = 0.053 for post hoc comparison between standard and incremental.